Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Obstetrics/Gynecology (Women’s Health) | Endocrinology | Family Medicine
Disease Category: Endometriosis
Location: United States, OR

Clinical Trial Details

Overview

Research Study Summary

If you have endometriosis, you may qualify for a medical research study.

Purpose

"A randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of Elagolix in subjects with moderate to severe endometriosis-associated pain."

The purpose of this research study is to test the safety and effectiveness of the study drug at different doses compared to placebo in managing moderate to severe pain associated with endometriosis.

Participation in this study will last up to about 20 months and include 14 study visits to the study site and 7 study telephone contacts.

Patient Inclusion Criteria:

  • Female
  • Age 18-49
  • Diagnosis of endometriosis

Patient Exclusion Criteria:

  • Hysterectomy
  • Currently pregnant, or breast feeding
  • Planning a pregnancy within the next 24 months.

To Learn more
Phase

3

Gender

Female

Age

18 to 49 Years

Overall Status

Recruiting

Duration

20 Months

Facility Type

N/A

Contact

Julie K. Anderson, Site Director
Sunstone Medical Research, LLC
1904 E. Barnett Road
Medford, OR 97504
Phone: 541-973-2080
Fax: 541-973-2096

View Map

Research Center Information: Sunstone Medical Research, LLC

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 181449

Date Last Changed: July 18, 2013


DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.